Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) (ANéRAVIMM)
Rapid Declarative Neocortical Declarative Learning in Aging and Memory
Sponsor: Rennes University Hospital
This NA trial investigates Central Nervous System and Neurological Diseases and is currently ongoing. Rennes University Hospital leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Aug 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2023 — Aug 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Sep 2022 — May 2023 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rennes University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .